http://www.protocol-...roRNA-and-RNAi/
Old threads on "siRNA, microRNA and RNAi" are achived here
Started by bioforum, Feb 03 2009 11:27 PM
3 replies to this topic
#1
Posted 03 February 2009 - 11:27 PM
#2
Posted 21 April 2010 - 04:23 PM
I am quite confused about the differences between the mechanisms by which (i) antisense oligonucleotides, (ii) long dsRNA, and (iii) short 21-23 dsRNA act on RNAs to affect gene expression in human cells.
I heard that long piece of dsRNA (in both worms or plants) activate the RNAi pathway, in where the long dsRNA gets cleaved into siRNA (20-25nt) and ultimately cause SPECIFIC mRNA degradation via RISC. Does this mean I should talk about the exogenous siRNA here? But long dsRNA cause broad/global effect!! I am confused...
In addition, both siRNA and miRNA are in definition a size of 19-25nt, where both have larger sized precursors. I do need clarification on these definitions. In addtion, isn't miRNA as a definition a endogenous single-stranded RNA?
I heard that long piece of dsRNA (in both worms or plants) activate the RNAi pathway, in where the long dsRNA gets cleaved into siRNA (20-25nt) and ultimately cause SPECIFIC mRNA degradation via RISC. Does this mean I should talk about the exogenous siRNA here? But long dsRNA cause broad/global effect!! I am confused...
In addition, both siRNA and miRNA are in definition a size of 19-25nt, where both have larger sized precursors. I do need clarification on these definitions. In addtion, isn't miRNA as a definition a endogenous single-stranded RNA?
#3
Posted 15 February 2012 - 08:30 AM
Hi, Your questions are really broad. I hope these links will at-least help you to find the answer. Yes, you are right, miRNA is endogenous single stranded RNA.
http://www.ncbi.nlm....pubmed/19389436
http://www.gene-quan...si-rna-2006.pdf
http://www.nature.co...rnai/index.html
Good luck
http://www.ncbi.nlm....pubmed/19389436
http://www.gene-quan...si-rna-2006.pdf
http://www.nature.co...rnai/index.html
Good luck
Edited by ravibiosciences, 15 February 2012 - 08:31 AM.
#4
Posted 15 February 2012 - 11:31 AM
These might also help.
------------------------------
Kole R, Krainer AR, Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov. 2012 Jan 20. doi: 10.1038/nrd3625. [Epub ahead of print]
http://www.nature.co...ll/nrd3625.html
------------------------------
Summerton J. Morpholino, siRNA, and S-DNA Compared: Impact of Structure and Mechanism of Action on Off-Target Effects and Sequence Specificity. Med Chem. 2007;7(7):651-660
http://www.benthamdi...00007/0003R.SGM
------------------------------
Kole R, Krainer AR, Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov. 2012 Jan 20. doi: 10.1038/nrd3625. [Epub ahead of print]
http://www.nature.co...ll/nrd3625.html
------------------------------
Summerton J. Morpholino, siRNA, and S-DNA Compared: Impact of Structure and Mechanism of Action on Off-Target Effects and Sequence Specificity. Med Chem. 2007;7(7):651-660
http://www.benthamdi...00007/0003R.SGM
Jon D. Moulton
Gene Tools, LLC
www.gene-tools.com
Gene Tools, LLC
www.gene-tools.com














